Literature DB >> 30325682

Regulatory T Cells and Their Association with Serum Markers and Symptoms in Systemic Lupus Erythematosus and Rheumatoid Arthritis.

Vikas Kailashiya1, Usha Singh1, Ranjan Rana1, Nand Kumar Singh2, Debabrata Dash3, Jyotsna Kailashiya3.   

Abstract

PURPOSE: Impairment in number and functions of regulatory T cells (Treg) has been found to be associated with many autoimmune diseases including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). This study was conducted to identify and compare Treg by flow cytometry using two different staining approaches.
METHODS: Treg were identified by using CD4+CD25+high and CD4+CD25+CD127dim staining approaches in SLE and RA patients and healthy controls. Association of both identified Treg levels with various serum markers and clinical presentation was also examined.
RESULTS: Blood CD4+CD25+CD127dim cells levels were 11.4+3.57 %, 9.76+2.37 % and 6.95+1.16 %; while CD4+CD25+high cells were 1.46+1.09 %, 0.95+0.59 % and 1.87+1.14 % in SLE patients, RA patients and healthy controls respectively. Number of CD4+CD25+CD127dim cells was higher than CD4+CD25+high cells in blood samples of all three study groups. Levels of CD4+CD25+CD127dim cells were significantly higher in SLE and RA patients, compared to healthy controls, but this difference was not observed for CD4+CD25+high Treg. CD4+CD25+high levels showed significant correlation with serum C4, IFN-γ and IL-10 levels in healthy subjects and with C4 levels and fever in SLE patients. CD4+CD25+CD127dim levels showed significant association with alopecia and oral ulcers in SLE patients only, but no correlation with measured serum markers.
CONCLUSION: Results suggest that both staining approaches detect Treg differently and also that Treg play different role in pathogenesis of SLE and RA.

Entities:  

Keywords:  CD4+CD25+CD127dim cells; CD4+CD25+high cells; IFN-γ; IL-10; TGF-β

Mesh:

Substances:

Year:  2018        PMID: 30325682     DOI: 10.1080/08820139.2018.1527852

Source DB:  PubMed          Journal:  Immunol Invest        ISSN: 0882-0139            Impact factor:   3.657


  5 in total

Review 1.  Treg cells in autoimmunity: from identification to Treg-based therapies.

Authors:  Lisa Göschl; Clemens Scheinecker; Michael Bonelli
Journal:  Semin Immunopathol       Date:  2019-04-05       Impact factor: 9.623

2.  VAV1 Gene Polymorphisms in Patients with Rheumatoid Arthritis.

Authors:  Andrzej Pawlik; Damian Malinowski; Agnieszka Paradowska-Gorycka; Krzysztof Safranow; Violetta Dziedziejko
Journal:  Int J Environ Res Public Health       Date:  2020-05-05       Impact factor: 3.390

3.  Blunted Expansion of Regulatory T Lymphocytes Is Associated With Increased Bacterial Translocation in Patients With Major Depressive Disorder.

Authors:  Miguel Angel Alvarez-Mon; Ana Maria Gomez-Lahoz; Arantxa Orozco; Guillermo Lahera; M Dolores Sosa-Reina; David Diaz; Agustin Albillos; Javier Quintero; Patricio Molero; Jorge Monserrat; Melchor Alvarez-Mon
Journal:  Front Psychiatry       Date:  2021-01-08       Impact factor: 4.157

4.  The proportion and phenotypic changes of CD4+CD25-Foxp3+ T cells in patients with untreated rheumatoid arthritis.

Authors:  Bomiao Ju; Li Zhu; Jing Wang; Jian Zheng; Zhiming Hao; Jing Luo; Jing Zhang; Nan Hu; Qi An; Xiuyuan Feng; Yongwei Huo; Lan He
Journal:  BMC Immunol       Date:  2022-09-06       Impact factor: 3.594

5.  T-Cell Dependent Immunogenicity of Protein Therapeutics Pre-clinical Assessment and Mitigation-Updated Consensus and Review 2020.

Authors:  Vibha Jawa; Frances Terry; Jochem Gokemeijer; Shibani Mitra-Kaushik; Brian J Roberts; Sophie Tourdot; Anne S De Groot
Journal:  Front Immunol       Date:  2020-06-30       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.